Indications for the presence of an atypical protease-activated receptor on rat platelets

Annals of Hematology

Volumn 79, Issue 11, 2000, Pages 604-611

  Ruef, J ^a   Kacharava, A ^a   Pohl, J ^a   Bode Runge, C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Protease activated receptor; Rat platelets; Thrombin receptor; Thrombin receptor activating peptides

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN RECEPTOR;

ANIMAL CELL; ARTICLE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; HUMANS; PEPTIDE FRAGMENTS; PEPTIDES; PLATELET AGGREGATION; RATS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN;

EID: 0033694824     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000211     Document Type: Article

References (45)

1. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
2. Sol sherry lecture in thrombosis. How thrombin talks to cells. Molecular mechanisms and roles in vivo
3. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
4. Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo
5. Inhibition of α-thrombin receptor signaling by a G-protein coupled receptor kinase
6. Expression of functional thrombin receptors in Xenopus oocytes injected with human endothelial cell mRNA
7. +-mobilizing alpha-thrombin receptors in mRNA-injected Xenopus oocytes
8. Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor
9. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin
10. Thrombin receptor-activating peptides unlike thrombin are insufficient for platelet activation in most species
11. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets
12. Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, regulation by protein kinases
13. Biological consequences of thrombin receptor deficiency in mice
14. Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide
15. Metabolism and function of human platelets washed by albumin density gradient separation
16. A peptide ligand of the human thrombin receptor antagonizes a-thrombin and partially activates platelets
17. Structure-activity analysis of synthetic α-thrombin-receptor-activating peptides
18. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides
19. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor
20. Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets
21. Post-receptor events associated with thrombin-induced platelet activation
22. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140
23. Correlation between thrombin-induced prostacyclin production and inositol triphosphate and cytosolic free calcium levels in cultured human endothelial cells
24. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
25. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function
26. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus
27. Structure-function relationship in the interaction of alpha-thrombin with blood platelets
28. Role of the thrombin receptor in development and evidence for a second receptor
29. Altered vascular injury responses in mice deficient in protease-activated receptor-1
30. Protease-activated receptor 3 is a second thrombin receptor in humans
31. A dual thrombin receptor system for platelet activation
32. Cloning and characterization of human protease-activated receptor 4
33. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides
34. The human proteinase-activated receptor-3 (PAR-3) gene. Identification with in a Par gene cluster and characterization in vascular endothelial cell and platelets
35. Protease-activated G protein-coupled receptors on human platelets and endothelial cells
36. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1
37. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries
38. Proteinase-activated receptor 2 (PAR2)-activating peptides: Identification of a receptor distinct from PAR2 that regulates intestinal transport
39. Gene locus structure and chromosomal localization of the protease-activated receptor gene family
40. Proteolytically activated receptor-3. A member of an emerging gene family of protease receptors expressed on vascular endothelial cells
41. The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin
42. Purification and preliminary physicochemical characterization of human platelet membrane-glycoprotein V
43. Glycoprotein V is not the thrombin activation receptor on human blood platelets
44. Development of potent thrombin receptor antagonist peptides
45. Therapeutic inhibition of thrombin activities, receptors, and production